Aura Biosciences, Inc.
AURA
$7.93
-$0.26-3.18%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -22.17% | -27.94% | -25.65% | -20.40% | -13.76% |
| Total Depreciation and Amortization | -7.69% | -8.60% | -8.16% | -5.11% | -5.56% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 68.16% | 62.44% | 44.65% | 38.99% | 25.03% |
| Change in Net Operating Assets | 326.00% | 939.22% | 318.52% | 348.05% | -159.49% |
| Cash from Operations | -6.19% | -20.46% | -13.61% | -9.49% | -24.99% |
| Capital Expenditure | 64.33% | 55.15% | 15.10% | -96.51% | -76.73% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -48.57% | 172.47% | 336.02% | 344.84% | 161.87% |
| Cash from Investing | -48.28% | 169.55% | 327.68% | 336.78% | 160.39% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 3,269.59% | -45.21% | -49.58% | -98.52% | -98.36% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 4,737.30% | -20.32% | -24.92% | -98.52% | -98.36% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 396.33% | 173.34% | 537.25% | 197.66% | 88.34% |